title: Financial policy issues for HIV pre-exposure prophylaxis: cost and access to insurance.
authors.affiliation: Mid-Atlantic Permanente Research Institute, Rockville, Maryland 20852, USA. michael.horberg@kp.org
authors.forename: Michael
authors.initials: M
authors.lastname: Horberg
authors.forename: Brian
authors.initials: B
authors.lastname: Raymond
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000191:economics*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000191:economics; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D019458:Insurance Coverage; D007348:Insurance, Health; D009943:Organophosphorus Compounds / Q000191:economics*; D011322:Primary Prevention / Q000191:economics*
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D009943:Organophosphorus Compounds; D003841:Deoxycytidine